Nifty

:

25114.00

Sensex

:

81904.70

108.50 (0.43%)
355.97 (0.44%)

Login

Nifty
Sensex

:
:

25114.00
81904.70

108.50 (0.43%)
355.97 (0.44%)

RPG Life Sciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

72/99

BSE: 532983 | NSE: RPGLIFE

Watchlist

NSE BSE

2380.30

12-Sep-2025

Open
High
Low
Previous Close

2383
2403.4
2355.9
2389.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

11398
27165052.5
2974.95
1835

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,933.72
21.52
8

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,794.11
1.01%
7.06

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.87
10.92
8.41

EBITDA CAGR (%)

10 Years
5 Years
3 Years

21.70
17.57
8.96

PAT CAGR (%)

10 Years
5 Years
3 Years

31.76
35.58
39.40

P:E (Median)

8 Years
5 Years
3 Years

23.41
22.32
28.61

P:BV (Average)

8 Years
5 Years
3 Years

5.30
5.63
6.91

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.13
15.54
18.84

Earnings Forecasts:

(Updated: 15-09-2025)

Description 2024 2025 2026 2027
Adj EPS 110.8
P/E Ratio 21.48
Revenue 653.43
EBITDA 159.65
Net Income 183.24
ROA 31.3
P/B Ratio 7.42
ROE 40.48
FCFF 44.42
FCFF Yield 1.2
Net Debt -265.51
BVPS 320.77

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 168.92 165.42 2.12% 143.09 126.99 12.68% 172.71 153.70 12.37% 172.21 153.58 12.13%
Expenses 133.45 126.35 5.62% 117.60 106.27 10.66% 123.55 115.80 6.69% 126.28 116.29 8.59%
EBITDA 35.47 39.07 -9.21% 25.49 20.72 23.02% 49.16 37.90 29.71% 45.93 37.29 23.17%
EBIDTM 21.00% 23.62% 17.81% 16.32% 28.46% 24.66% 26.67% 24.28%
Other Income 5.23 2.37 120.68% 5.06 1.65 206.67% 3.31 1.92 72.40% 1.94 1.83 6.01%
Interest 0.13 0.15 -13.33% 0.18 0.14 28.57% 0.12 0.14 -14.29% 0.17 0.10 70.00%
Depreciation 5.14 5.29 -2.84% 5.37 4.49 19.60% 5.46 4.14 31.88% 5.31 4.23 25.53%
PBT 35.43 36.00 -1.58% 134.90 17.74 660.43% 46.89 35.54 31.94% 15.09 34.79 -56.63%
Tax 9.14 9.24 -1.08% 17.55 4.50 290.00% 11.96 9.08 31.72% 10.89 8.93 21.95%
PAT 26.29 26.76 -1.76% 117.35 13.24 786.33% 34.93 26.46 32.01% 4.20 25.86 -83.76%
PATM 15.56% 16.18% 82.01% 10.43% 20.22% 17.22% 2.44% 16.84%
EPS 15.93 16.22 -1.79% 71.12 8.02 786.78% 21.17 16.04 31.98% 2.55 15.67 -83.73%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 656.93 653.43 582.05 512.81 440.16 389.14 375.57 330.16 343.95 293.64 279.32 Net Sales Growth 9.54% 12.26% 13.50% 16.51% 13.11% 3.61% 13.75% -4.01% 17.13% 5.13% Cost Of Goods Sold 219.02 196.65 167.82 156.64 127.59 121.27 119.63 103.93 106.87 96.02 84.94 Gross Profit 437.91 456.78 414.23 356.17 312.57 267.87 255.94 226.23 237.08 197.62 194.38 GP Margin 66.66% 69.90% 71.17% 69.45% 71.01% 68.84% 68.15% 68.52% 68.93% 67.30% 69.59% Total Expenditure 500.88 494.46 452.91 409.28 353.00 318.37 315.67 295.73 306.89 265.01 257.02 Power & Fuel Cost - 17.66 14.36 13.65 12.69 11.27 11.54 10.38 10.44 9.10 11.23 % Of Sales - 2.70% 2.47% 2.66% 2.88% 2.90% 3.07% 3.14% 3.04% 3.10% 4.02% Employee Cost - 126.14 132.15 117.06 99.97 94.66 90.97 89.93 90.14 75.59 74.13 % Of Sales - 19.30% 22.70% 22.83% 22.71% 24.33% 24.22% 27.24% 26.21% 25.74% 26.54% Manufacturing Exp. - 46.35 43.80 36.62 37.86 28.79 21.85 18.98 21.86 20.63 26.88 % Of Sales - 7.09% 7.53% 7.14% 8.60% 7.40% 5.82% 5.75% 6.36% 7.03% 9.62% General & Admin Exp. - 48.64 41.63 37.14 33.97 28.54 32.76 34.32 35.76 31.57 24.58 % Of Sales - 7.44% 7.15% 7.24% 7.72% 7.33% 8.72% 10.39% 10.40% 10.75% 8.80% Selling & Distn. Exp. - 46.22 37.85 35.62 32.27 25.47 20.13 18.61 22.51 17.90 16.44 % Of Sales - 7.07% 6.50% 6.95% 7.33% 6.55% 5.36% 5.64% 6.54% 6.10% 5.89% Miscellaneous Exp. - 12.80 15.30 12.55 8.65 8.37 18.79 19.58 19.31 14.20 16.44 % Of Sales - 1.96% 2.63% 2.45% 1.97% 2.15% 5.00% 5.93% 5.61% 4.84% 6.74% EBITDA 156.05 158.97 129.14 103.53 87.16 70.77 59.90 34.43 37.06 28.63 22.30 EBITDA Margin 23.75% 24.33% 22.19% 20.19% 19.80% 18.19% 15.95% 10.43% 10.77% 9.75% 7.98% Other Income 15.54 14.33 7.21 4.80 3.08 1.07 0.99 0.80 2.36 9.78 1.96 Interest 0.60 1.59 1.44 1.15 1.41 1.79 2.76 4.86 4.72 3.64 2.49 Depreciation 21.28 21.43 17.07 15.50 15.66 16.47 16.36 15.32 14.34 11.31 10.15 PBT 232.31 150.28 117.84 91.68 73.17 53.58 41.77 15.05 20.36 23.46 11.62 Tax 49.54 49.64 30.18 24.04 21.69 13.58 7.44 4.24 6.91 2.45 0.00 Tax Rate 21.32% 21.32% 25.61% 26.22% 29.64% 25.35% 20.41% 28.17% 33.94% 10.44% 0.00% PAT 182.77 183.24 87.66 67.64 51.48 40.00 29.01 10.81 13.45 21.01 11.62 PAT before Minority Interest 182.77 183.24 87.66 67.64 51.48 40.00 29.01 10.81 13.45 21.01 11.62 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 27.82% 28.04% 15.06% 13.19% 11.70% 10.28% 7.72% 3.27% 3.91% 7.16% 4.16% PAT Growth 97.97% 109.03% 29.60% 31.39% 28.70% 37.88% 168.36% -19.63% -35.98% 80.81% EPS 110.77 111.05 53.13 40.99 31.20 24.24 17.58 6.55 8.15 12.73 7.04

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 530.53 374.85 307.60 255.77 216.45 176.57 160.50 154.75 147.01 133.59 Share Capital 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 Total Reserves 517.30 361.62 294.37 242.54 203.22 163.34 147.27 141.52 133.78 120.36 Non-Current Liabilities 6.45 6.48 8.97 8.73 7.19 8.75 9.58 8.37 10.77 22.45 Secured Loans 0.00 0.00 0.00 0.01 0.08 0.22 4.63 10.11 15.89 0.13 Unsecured Loans 0.00 0.00 0.00 0.29 0.66 1.30 1.95 0.12 0.16 0.11 Long Term Provisions 4.54 4.03 3.98 3.04 3.13 8.50 6.19 2.79 2.32 19.60 Current Liabilities 119.83 130.96 102.78 80.11 79.69 82.59 77.82 120.71 78.68 66.80 Trade Payables 79.39 71.02 64.69 45.50 47.44 44.41 25.13 51.87 28.65 33.71 Other Current Liabilities 24.33 45.05 26.23 19.87 18.12 20.30 13.32 18.47 14.91 10.17 Short Term Borrowings 0.00 0.00 0.00 0.21 0.52 5.12 29.04 37.92 24.01 21.96 Short Term Provisions 16.11 14.89 11.86 14.53 13.61 12.76 10.33 12.45 11.11 0.96 Total Liabilities 656.81 512.29 419.35 344.61 303.33 267.91 247.90 283.83 236.46 222.84 Net Block 171.83 113.53 124.26 103.71 113.30 122.89 127.64 130.80 136.67 109.26 Gross Block 276.05 221.52 220.01 186.37 180.44 173.81 162.55 150.65 142.43 189.83 Accumulated Depreciation 104.22 107.99 95.75 82.66 67.14 50.92 34.91 19.85 5.76 80.57 Non Current Assets 191.56 214.20 155.30 137.70 127.48 142.13 150.81 141.21 140.08 135.65 Capital Work in Progress 16.06 96.31 25.44 31.06 11.77 9.98 17.17 8.73 1.82 1.59 Non Current Investment 1.01 1.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 2.66 3.35 5.60 2.93 2.41 9.26 6.00 1.68 1.59 24.80 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 465.25 298.09 264.05 206.91 175.85 125.78 97.09 142.62 96.38 87.19 Current Investments 125.90 90.15 58.43 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 92.98 101.00 95.05 82.99 58.33 46.61 41.04 53.69 45.78 39.02 Sundry Debtors 86.76 49.13 37.43 32.99 57.42 63.33 38.90 68.13 39.28 36.99 Cash & Bank 139.61 36.47 57.04 70.26 40.75 1.11 0.77 0.94 1.60 0.80 Other Current Assets 20.00 4.86 5.41 6.64 19.35 14.73 16.38 19.86 9.72 10.38 Short Term Loans & Adv. 9.89 16.48 10.69 14.03 10.64 6.51 9.45 12.26 4.13 9.80 Net Current Assets 345.42 167.13 161.27 126.80 96.16 43.19 19.27 21.91 17.70 20.39 Total Assets 656.81 512.29 419.35 344.61 303.33 267.91 247.90 283.83 236.46 222.84

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 77.86 94.36 90.82 64.75 58.27 50.17 45.78 14.68 7.33 32.81 PBT 232.88 117.84 91.68 73.17 53.58 36.45 15.05 20.36 23.46 11.62 Adjustment -76.22 12.92 13.31 13.54 16.55 22.52 20.08 17.37 6.95 12.64 Changes in Working Capital -26.05 -7.09 11.06 -3.11 -3.53 -2.37 14.37 -19.35 -18.81 10.92 Cash after chg. in Working capital 130.61 123.67 116.05 83.60 66.60 56.60 49.50 18.38 11.60 35.18 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -52.75 -29.31 -25.23 -18.85 -8.33 -6.43 -3.72 -3.70 -4.27 -2.37 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -41.80 -79.15 -105.81 -34.66 -7.96 -10.70 -19.02 -15.54 -30.06 -15.25 Net Fixed Assets 25.72 -72.38 -28.02 -25.22 -8.42 -4.07 -20.34 -15.13 47.17 -15.19 Net Investments -35.75 -32.73 -58.43 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -31.77 25.96 -19.36 -9.44 0.46 -6.63 1.32 -0.41 -77.23 -0.06 Cash from Financing Activity -27.08 -20.31 -17.12 -13.51 -10.49 -39.30 -26.50 0.11 23.36 -17.58 Net Cash Inflow / Outflow 8.98 -5.10 -32.11 16.58 39.82 0.17 0.26 -0.75 0.63 -0.02 Opening Cash & Equivalents 19.72 24.82 56.93 40.36 0.54 0.37 0.11 0.86 0.23 0.25 Closing Cash & Equivalent 28.70 19.72 24.82 56.94 40.36 0.54 0.37 0.11 0.86 0.23

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 320.80 226.67 186.00 154.66 130.88 106.77 97.05 93.58 88.89 80.78 ROA 31.35% 18.82% 17.71% 15.89% 14.00% 11.25% 4.07% 5.17% 9.15% 5.34% ROE 40.48% 25.69% 24.01% 21.80% 20.36% 17.21% 6.86% 8.91% 14.98% 8.98% ROCE 51.79% 34.96% 32.92% 31.46% 27.27% 20.35% 9.81% 12.52% 15.58% 8.97% Fixed Asset Turnover 2.82 2.83 2.73 2.61 2.37 2.23 2.11 2.37 1.85 1.59 Receivable days 35.40 25.32 23.17 34.41 52.52 49.68 59.16 56.47 45.37 48.80 Inventory Days 50.53 57.35 58.57 53.79 45.64 42.59 52.36 52.29 50.44 46.22 Payable days 139.59 147.58 128.38 132.94 138.23 44.01 56.38 53.51 47.24 47.03 Cash Conversion Cycle -53.67 -64.92 -46.65 -44.74 -40.07 48.25 55.15 55.25 48.57 47.99 Total Debt/Equity 0.00 0.00 0.00 0.00 0.01 0.07 0.23 0.35 0.30 0.17 Interest Cover 147.47 82.83 80.72 52.89 30.93 14.21 4.10 5.31 7.45 5.67

Top Investors:

authum investment and infrastructure limited

quant mutual fund - quant active fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

RPG Life Sciences - Quarterly Results
25th Jul 2025, 19:14 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback